Caffeine, Codeine, Acetylsalicylic acid

Dolviran 400 MG/9,6 MG/50 MG Comprimidos

50 mg + 9,6 mg + 400 mg comprimidoSpainMarketedAuthorised 31 Jan 1952

In other countries

The same active substances on other registers, the same brand first.

Acetylsalicylic Acid, Caffeine and 8 MG Codeine PhosphateCanada · 375 MG + 15 MG + 8 MG · Tablet · Cellchem Pharmaceuticals INC.Same form
222 TabletsCanada · 375 MG + 30 MG + 8 MG · Tablet · Mcneil Consumer Healthcare Division of Johnson & Johnson INCSame form
282 TabCanada · 375 MG + 30 MG + 15 MG · Tablet · Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Same form

Packs

Pack	Code	Status
DOLVIRAN 400 MG/9,6 MG/50 MG COMPRIMIDOS, 20 comprimidos	650097

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Caffeine, Codeine, Acetylsalicylic acid

Dolviran 400 MG/9,6 MG/50 MG Comprimidos

50 mg + 9,6 mg + 400 mg comprimidoSpainMarketedAuthorised 31 Jan 1952

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
DOLVIRAN 400 MG/9,6 MG/50 MG COMPRIMIDOS, 20 comprimidos	650097

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Caffeine, Codeine, Acetylsalicylic acid
Strength: 50 mg + 9,6 mg + 400 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 Jan 1952
Registration: 16657
Marketing authorisation holder: Kern Pharma S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica